Steigerwald, Gordon & Koch Inc. / AMGN
Steigerwald, Gordon & Koch Inc.’s Amgen Inc Position
Does Steigerwald, Gordon & Koch Inc. own Amgen Inc (AMGN)? Yes — 70.9K shares worth $25M (+2.56% of its 13F portfolio) as of Q1 2026, up from 70.6K shares the prior filed quarter.
Position Value
$25M
Q1 2026
Shares
70.9K
% of Portfolio
+2.56%
Quarters Held
30
currently held
Position History AMGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 70.9K | $25M | +2.56% |
| Q4 2025 | 70.6K | $23M | +2.22% |
| Q3 2025 | 71.3K | $20M | +1.93% |
| Q2 2025 | 70.9K | $20M | +2.09% |
| Q1 2025 | 70.1K | $22M | +2.44% |
| Q4 2024 | 70.5K | $18M | +2.07% |
| Q3 2024 | 70.0K | $23M | +2.46% |
| Q2 2024 | 68.5K | $21M | +2.59% |
| Q1 2024 | 67.3K | $19M | +2.38% |
| Q4 2023 | 66.4K | $19M | +2.59% |
| Q3 2023 | 65.4K | $18M | +2.68% |
| Q2 2023 | 64.1K | $14M | +2.09% |
| Q1 2023 | 62.5K | $15M | +2.26% |
| Q4 2022 | 60.9K | $16M | +2.54% |
| Q3 2022 | 59.9K | $14M | +2.47% |
| Q2 2022 | 58.7K | $14M | +2.49% |
| Q1 2022 | 58.3K | $14M | +2.15% |
| Q4 2021 | 57.5K | $13M | +1.95% |
| Q3 2021 | 55.7K | $12M | +1.94% |
| Q2 2021 | 55.5K | $14M | +2.24% |
| Q1 2021 | 54.0K | $13M | +2.50% |
| Q4 2020 | 54.2K | $12M | +2.53% |
| Q3 2020 | 53.4K | $14M | +3.21% |
| Q2 2020 | 53.3K | $13M | +3.33% |
| Q1 2020 | 52.8K | $11M | +3.63% |
| Q4 2019 | 55.2K | $13M | +3.13% |
| Q3 2019 | 55.5K | $11M | +2.74% |
| Q2 2019 | 55.4K | $10M | +2.64% |
| Q1 2019 | 55.5K | $11M | +2.78% |
| Q4 2018 | 56.2K | $11M | +3.26% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Steigerwald, Gordon & Koch Inc.’s full portfolio or all institutional holders of AMGN.